Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 7951536, 11 pages
http://dx.doi.org/10.1155/2016/7951536
Review Article

Multidisciplinary Management of Pituitary Apoplexy

1Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
2Unit of Neurosurgery, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy
3Unit of Neuroradiology, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy
4Unit of Ophthalmology, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy

Received 26 June 2016; Revised 19 October 2016; Accepted 6 November 2016

Academic Editor: Sabrina Corbetta

Copyright © 2016 Adriana Albani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Bailey, “Pathological report of a case of acromegaly, with special reference to the lesions in the hypophysis cerebri and in the thyroid gland; and a case of haemorrhage in to the pituitary,” Philadelphia Medical Journal, vol. 1, pp. 789–792, 1898. View at Google Scholar
  2. A. Fernandez, N. Karavitaki, and J. A. H. Wass, “Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK),” Clinical Endocrinology, vol. 72, no. 3, pp. 377–382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Raappana, J. Koivukangas, T. Ebeling, and T. Pirilä, “Incidence of pituitary adenomas in Northern Finland in 1992–2007,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp. 4268–4275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Sibal, S. G. Ball, V. Connolly et al., “Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases,” Pituitary, vol. 7, no. 3, pp. 157–163, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. P. L. Semple, J. A. Jane Jr., and E. R. Laws Jr., “Clinical relevance of precipitating factors in pituitary apoplexy,” Neurosurgery, vol. 61, no. 5, pp. 956–961, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Wakai, T. Fukushima, A. Teramoto, and K. Sano, “Pituitary apoplexy: its incidence and clinical significance,” Journal of Neurosurgery, vol. 55, no. 2, pp. 187–193, 1981. View at Publisher · View at Google Scholar · View at Scopus
  7. N. G. Dan, R. I. D. Feiner, M. T. W. Houang, and J. J. Turner, “Pituitary apoplexy in association with lymphocytic hypophysitis,” Journal of Clinical Neuroscience, vol. 9, no. 5, pp. 577–580, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Husain, A. Zouzias, V. V. Kanumuri, J. A. Eloy, and J. K. Liu, “Idiopathic granulomatous hypophysitis presenting as pituitary apoplexy,” Journal of Clinical Neuroscience, vol. 21, no. 3, pp. 510–512, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Capatina, W. Inder, N. Karavitaki, and J. A. H. Wass, “Management of endocrine disease: pituitary tumour apoplexy,” European Journal of Endocrinology, vol. 172, no. 5, pp. R179–R190, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. S. S. Chhiber, A. R. Bhat, S. H. Khan et al., “Apoplexy in sellar metastasis: a case report and review of literature,” Turkish Neurosurgery, vol. 21, no. 2, pp. 230–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. C. Bills, F. B. Meyer, E. R. Laws Jr. et al., “A retrospective analysis of pituitary apoplexy,” Neurosurgery, vol. 33, no. 4, pp. 602–609, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. Z.-H. Liu, P.-H. Tu, P.-C. Pai, N.-Y. Chen, S.-T. Lee, and C.-C. Chuang, “Predisposing factors of pituitary hemorrhage,” European Journal of Neurology, vol. 19, no. 5, pp. 733–738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. E. H. Oldfield and M. J. Merrill, “Apoplexy of pituitary adenomas: the perfect storm,” Journal of Neurosurgery, vol. 122, no. 6, pp. 1444–1449, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Mohr and J. Hardy, “Hemorrhage, necrosis, and apoplexy in pituitary adenomas,” Surgical Neurology, vol. 18, no. 3, pp. 181–189, 1982. View at Publisher · View at Google Scholar · View at Scopus
  15. B. R. Randall and W. T. Couldwell, “Apoplexy in pituitary microadenomas,” Acta Neurochirurgica, vol. 152, no. 10, pp. 1737–1740, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. D. L. Möller-Goede, M. Brändle, K. Landau, R. L. Bernay, and C. Schmid, “Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome,” European Journal of Endocrinology, vol. 164, no. 1, pp. 37–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. R. Nourizadeh and F. W. Pitts, “Hemorrhage into pituitary adenoma during anticoagulant therapy,” The Journal of the American Medical Association, vol. 193, pp. 623–625, 1965. View at Publisher · View at Google Scholar · View at Scopus
  18. A. S. Willamowicz and R. L. Houlden, “Pituitary apoplexy after anticoagulation for unstable angina,” Endocrine Practice, vol. 5, no. 5, pp. 273–276, 1999. View at Publisher · View at Google Scholar
  19. F. Doglietto, E. Costi, A. B. Villaret, D. Mardighian, M. M. Fontanella, and A. Giustina, “New oral anticoagulants and pituitary apoplexy,” Pituitary, vol. 19, no. 2, pp. 232–234, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Uemura, F. Miyashita, R. Shimomura, J. Fujinami, and K. Toyoda, “Pituitary apoplexy during treatment with dabigatran,” Neurology and Clinical Neuroscience, vol. 1, no. 2, pp. 82–83, 2013. View at Publisher · View at Google Scholar
  21. G. A. Balarini Lima, E. D. O. Machado, C. M. Santos Silva, P. N. Filho, and M. R. Gadelha, “Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline,” Pituitary, vol. 11, no. 3, pp. 287–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Yamaji, M. Ishibashi, K. Kosaka et al., “Pituitary apoplexy in acromegaly during bromocriptine therapy,” Acta Endocrinologica, vol. 98, no. 2, pp. 171–177, 1981. View at Google Scholar · View at Scopus
  23. E. Chng and R. Dalan, “Pituitary apoplexy associated with cabergoline therapy,” Journal of Clinical Neuroscience, vol. 20, no. 12, pp. 1637–1643, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Knoepfelmacher, M. C. Gomes, M. E. Melo, and B. B. Mendonca, “Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma,” Pituitary, vol. 7, no. 2, pp. 83–87, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Pinto, M. Zerah, C. Trivin, and R. Brauner, “Pituitary apoplexy in an adolescent with prolactin-secreting adenoma,” Hormone Research, vol. 50, no. 1, pp. 38–41, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Carija and D. Vucina, “Frequency of pituitary tumor apoplexy during treatment of prolactinomas with dopamine agonists: a systematic review,” CNS and Neurological Disorders - Drug Targets, vol. 11, no. 8, pp. 1012–1014, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. S. Bevan, J. Webster, C. W. Burke, and M. F. Scanlon, “Dopamine agonists and pituitary tumor shrinkage,” Endocrine Reviews, vol. 13, no. 2, pp. 220–240, 1992. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Colao, A. Di Sarno, M. L. Landi et al., “Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 6, pp. 2247–2252, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. E. R. Cardoso and E. W. Peterson, “Pituitary apoplexy: a review,” Neurosurgery, vol. 14, no. 3, pp. 363–373, 1984. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Reichenthal, R. S. Manor, and M. N. Shalit, “Pituitary apoplexy during carotid angiography,” Acta Neurochirurgica, vol. 54, no. 3-4, pp. 251–255, 1980. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Suga, S. Kagawa, H. Goto, K. Yoshioka, and T. Hosoya, “A case of pituitary adenoma progressing to pituitary apoplexy on the occasion of cerebral angiography,” Neurological Surgery, vol. 24, no. 5, pp. 475–479, 1996. View at Google Scholar · View at Scopus
  32. M. Khandelwal, A. Chhabra, and S. Krishnan, “Pituitary apoplexy following bilateral total knee arthroplasty [5],” Journal of Postgraduate Medicine, vol. 51, no. 2, pp. 155–156, 2005. View at Google Scholar · View at Scopus
  33. V. Peck, A. Lieberman, P. Pinto, and A. Culliford, “Pituitary apoplexy following open-heart surgery,” New York State Journal of Medicine, vol. 80, no. 4, pp. 641–643, 1980. View at Google Scholar · View at Scopus
  34. M. L. Slavin and M. Budabin, “Pituitary apoplexy associated with cardiac surgery,” American Journal of Ophthalmology, vol. 98, no. 3, pp. 291–296, 1984. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Mukhida and G. Kolyvas, “Pituitary apoplexy following cardiac surgery,” Canadian Journal of Neurological Sciences, vol. 34, no. 3, pp. 390–393, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. Y.-J. Bao, X.-G. Li, Z.-T. Jing, S.-W. Ou, A.-H. Wu, and Y.-J. Wang, “Pituitary apoplexy complicated with subarachnoid hemorrhage caused by incidentaloma following a head injury: case report,” Chinese Medical Journal, vol. 120, no. 24, pp. 2341–2343, 2007. View at Google Scholar · View at Scopus
  37. V. Biousse, N. J. Newman, and N. M. Oyesiku, “Precipitating factors in pituitary apoplexy,” Journal of Neurology Neurosurgery and Psychiatry, vol. 71, no. 4, pp. 542–545, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Yamamoto, S. Yano, J. Kuroda, Y. Hasegawa, T. Hide, and J. Kuratsu, “Pituitary apoplexy associated with endocrine stimulation test: endocrine stimulation test, treatment, and outcome,” Case Reports in Endocrinology, vol. 2012, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  39. B. M. Arafah, H. C. Taylor, R. Salazar, H. Saadi, and W. R. Selman, “Apoplexy of a pituitary adenoma after dynamic testing with gonadotropin-releasing hormone,” The American Journal of Medicine, vol. 87, no. 1, pp. 103–105, 1989. View at Publisher · View at Google Scholar · View at Scopus
  40. A. J. Chapman, G. Williams, A. D. Hockley, and D. R. London, “Pituitary apoplexy after combined test of anterior pituitary function,” British Medical Journal, vol. 291, no. 6487, p. 26, 1985. View at Publisher · View at Google Scholar · View at Scopus
  41. H. S. Dökmetaş, A. Selçuklu, R. Çolak, K. Ünlühizarci, F. Bayram, and F. Keleştimur, “Pituitary apoplexy probably due to TRH and GnRH stimulation tests in a patient with acromegaly,” Journal of Endocrinological Investigation, vol. 22, no. 9, pp. 698–700, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Foppiani, S. Piredda, R. Guido, R. Spaziante, and M. Giusti, “Gonadotropin-releasing hormone-induced partial empty sella clinically mimicking pituitary apoplexy in a woman with a suspected non-secreting macroadenoma,” Journal of Endocrinological Investigation, vol. 23, no. 2, pp. 118–121, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Kiliçli, H. S. Dökmetaş, and M. Gürelik, “Development of pituitary apoplexy during TRH/GnRH test in a patient with pituitary macroadenoma,” Singapore Medical Journal, vol. 51, no. 11, pp. e179–e181, 2010. View at Google Scholar · View at Scopus
  44. D. H. Lee, M. Y. Chung, D. J. Chung et al., “Apoplexy of pituitary macroadenoma after combined test of anterior pituitary function,” Endocrine Journal, vol. 47, no. 3, pp. 329–333, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Matsuura, N. Saeki, M. Kubota, H. Murai, and A. Yamaura, “Infarction followed by hemorrhage in pituitary adenoma due to endocrine stimulation test,” Endocrine Journal, vol. 48, no. 4, pp. 493–498, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Rotman-Pikielny, N. Patronas, and D. A. Papanicolaou, “Pituitary apoplexy induced by corticotrophin-releasing hormone in a patient with Cushing's disease,” Clinical Endocrinology, vol. 58, no. 5, pp. 545–549, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Vassallo, Z. Rana, and S. Allen, “Pituitary apoplexy after stimulation tests,” Postgraduate Medical Journal, vol. 70, no. 824, pp. 444–445, 1994. View at Publisher · View at Google Scholar · View at Scopus
  48. O. Okuda, H. Umezawa, and M. Miyaoka, “Pituitary apoplexy caused by endocrine stimulation tests: a case report,” Surgical Neurology, vol. 42, no. 1, pp. 19–22, 1994. View at Publisher · View at Google Scholar · View at Scopus
  49. I. Szabolcs, N. Késmárki, K. Bor et al., “Apoplexy of a pituitary macroadenoma as a severe complication of preoperative thyrotropin-releasing hormone (TRH) testing,” Experimental and Clinical Endocrinology & Diabetes, vol. 105, no. 4, pp. 234–236, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. P. Xekouki, S. A. Mastroyiannis, D. Avgeropoulos et al., “Familial pituitary apoplexy as the only presentation of a novel AIP mutation,” Endocrine-Related Cancer, vol. 20, no. 5, pp. L11–L14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. H. S. Randeva, J. Schoebel, J. Byrne, M. Esiri, C. B. T. Adams, and J. A. H. Wass, “Classical pituitary apoplexy: clinical features, management and outcome,” Clinical Endocrinology, vol. 51, no. 2, pp. 181–188, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. L. A. Da Motta, P. A. de Mello, C. M. de Lacerda, A. P. Neto, L. D. da Motta, and M. F. Filho, “Pituitary apoplexy. Clinical course, endocrine evaluations and treatment analysis,” Journal of Neurosurgical Sciences, vol. 43, pp. 25–36, 1999. View at Google Scholar
  53. S. T. Onesti, T. Wisniewski, and K. D. Post, “Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patient,” Neurosurgery, vol. 26, no. 6, pp. 980–986, 1990. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Ayuk, E. J. McGregor, R. D. Mitchell, and N. J. L. Gittoes, “Acute management of pituitary apoplexy—surgery or conservative management?” Clinical Endocrinology, vol. 61, no. 6, pp. 747–752, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. P. C. Johnston, A. H. Hamrahian, R. J. Weil, and L. Kennedy, “Pituitary tumor apoplexy,” Journal of Clinical Neuroscience, vol. 22, no. 6, pp. 939–944, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Mohanty, P. N. Tandon, A. K. Banerji, and B. Prakash, “Haemorrhage into pituitary adenomas,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 40, no. 10, pp. 987–991, 1977. View at Publisher · View at Google Scholar · View at Scopus
  57. J. W. Findling, J. B. Tyrrell, D. C. Aron, P. A. Fitzgerald, C. B. Wilson, and P. H. Forsham, “Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma,” Journal of Clinical Endocrinology and Metabolism, vol. 52, no. 1, pp. 95–97, 1981. View at Publisher · View at Google Scholar · View at Scopus
  58. S. A. Peter, “Subclinical pituitary apoplexy.,” New York State Journal of Medicine, vol. 86, no. 12, pp. 656–657, 1986. View at Google Scholar · View at Scopus
  59. S. Rajasekaran, M. Venderpump, S. Baldeweg et al., “UK guidelines for the management of pituitary apoplexy,” Clinical Endocrinology, vol. 74, pp. 9–20, 2011. View at Google Scholar
  60. P. N. E. Imboden, N. De Tribolet, A. Lobrinus et al., “Apoplexy in pituitary macroadenoma: eight patients presenting in 12 months,” Medicine, vol. 84, no. 3, pp. 188–196, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Lubina, D. Olchovsky, M. Berezin, Z. Ram, M. Hadani, and I. Shimon, “Management of pituitary apoplexy: clinical experience with 40 patients,” Acta Neurochirurgica, vol. 147, no. 2, pp. 151–157, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Agrawal and A. K. Mahapatra, “Pituitary apoplexy and inappropriate ADH secretion,” Journal of Clinical Neuroscience, vol. 10, no. 2, pp. 260–261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. D. H. Zayour, W. R. Selman, and B. M. Arafah, “Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5649–5654, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Pelkonen, A. Kuusisto, J. Salmi et al., “Pituitary function after pituitary apoplexy,” The American Journal of Medicine, vol. 65, no. 5, pp. 773–778, 1978. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Louwerens, W. W. de Herder, P. T. E. Postema, H. L. J. Tanghe, and S. W. J. Lamberts, “Pituitary insufficiency and regression of acromegaly caused by pituitary apoplexy following cerebral angiography,” European Journal of Endocrinology, vol. 134, no. 6, pp. 737–740, 1996. View at Publisher · View at Google Scholar · View at Scopus
  66. P. J. Dunn, R. A. Donald, and E. A. Espiner, “Regression of acromegaly following pituitary apoplexy,” Australian and New Zealand Journal of Medicine, vol. 5, no. 4, pp. 369–372, 1975. View at Publisher · View at Google Scholar · View at Scopus
  67. V. Araya, I. Solis, M. Lemp, and S. Oviedo, “Partial remission of hypercortisolism in Cushing disease after pituitary apoplexy. A case report,” Revista Médica de Chile, vol. 126, pp. 1497–1501, 1998. View at Google Scholar
  68. J. Abbott and G. R. Kirkby, “Acute visual loss and pituitary apoplexy after surgery,” British Medical Journal, vol. 329, no. 7459, pp. 218–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. A. S. Dubuisson, A. Beckers, and A. Stevenaert, “Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients,” Clinical Neurology and Neurosurgery, vol. 109, no. 1, pp. 63–70, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Simon, D. Torpy, B. Brophy, P. Blumbergs, D. Selva, and J. L. Crompton, “Neuro-ophthalmic manifestations and outcomes of pituitary apoplexy—a life and sight-threatening emergency,” New Zealand Medical Journal, vol. 124, no. 1335, pp. 52–59, 2011. View at Google Scholar · View at Scopus
  71. S. J. Russel and K. K. Miller, “Pituitary apoplexy,” in Diagnosis and Management of Pituitary Disorders, B. Swearingen and B. M. K. Biller, Eds., pp. 353–375, Humana Press, Totowa, NJ, USA, 2008. View at Google Scholar
  72. T. M. Jenkins and A. T. Toosy, “Visual acuity, eye movements and visual fields,” in Pituitary Apoplexy, M. Turgut, A. K. Mahapatra, M. Powell, and N. Muthukumar, Eds., pp. 75–88, Springer, Berlin, Germany, 2014. View at Google Scholar
  73. Y. Kinoshita, A. Tominaga, S. Usui, K. Arita, K. Sugiyama, and K. Kurisu, “Impact of subclinical haemorrhage on the pituitary gland in patients with pituitary adenomas,” Clinical Endocrinology, vol. 80, no. 5, pp. 720–725, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. R. P. Glick and J. A. Tiesi, “Subacute pituitary apoplexy: clinical and magnetic resonance imaging characteristics,” Neurosurgery, vol. 27, no. 2, pp. 214–219, 1990. View at Publisher · View at Google Scholar · View at Scopus
  75. C. A. Kyle, R. A. Laster, E. M. Burton, and R. A. Sanford, “Subacute pituitary apoplexy: MR and CT appearance,” Journal of Computer Assisted Tomography, vol. 14, no. 1, pp. 40–44, 1990. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Piotin, D. Tampieri, D. A. Rüfenacht et al., “The various MRI patterns of pituitary apoplexy,” European Radiology, vol. 9, no. 5, pp. 918–923, 1999. View at Publisher · View at Google Scholar · View at Scopus
  77. P. C. Davis, J. C. Hoffman Jr., T. Spencer, G. T. Tindall, and I. F. Braun, “MR imaging of pituitary adenoma: CT, clinical, and surgical correlation,” American Journal of Neuroradiology, vol. 8, pp. 107–112, 1987. View at Google Scholar
  78. A. Boellis, A. di Napoli, A. Romano, and A. Bozzao, “Pituitary apoplexy: an update on clinical and imaging features,” Insights into Imaging, vol. 5, no. 6, pp. 753–762, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. B. Agrawal, K. Dziurzynski, M. Shariar Salamat, and M. Baskaya, “The temporal association of sphenoid sinus mucosal thickening on mr imaging with pituitary apoplexy,” Turkish Neurosurgery, vol. 22, no. 6, pp. 785–790, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Arita, K. Kurisu, A. Tominaga et al., “Thickening of sphenoid sinus mucosa during the acute stage of pituitary apoplexy: case report,” Journal of Neurosurgery, vol. 95, no. 5, pp. 897–901, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. L. Curto, S. Squadrito, B. Almoto et al., “MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case,” Pituitary, vol. 10, no. 3, pp. 299–305, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Turgut, Y. Özsunar, S. Başak, E. Güney, E. Kir, and I. Meteoğlu, “Pituitary apoplexy: an overview of 186 cases published during the last century,” Acta Neurochirurgica, vol. 152, no. 5, pp. 749–761, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. R.-X. Song, D.-K. Wang, Z. Wang et al., “Coexistence of aneurysmal subarachnoid hemorrhage and surgically identified pituitary apoplexy: a case report and review of the literature,” Journal of Medical Case Reports, vol. 8, no. 1, article no. 166, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. Z. Peng, D. Tian, H. Wang et al., “Epistaxis and pituitary apoplexy due to ruptured internal carotid artery aneurysm embedded within pituitary adenoma,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 11, pp. 14189–14197, 2015. View at Google Scholar
  85. H. Suzuki, M. Muramatsu, K. Murao, K. Kawaguchi, and T. Shimizu, “Pituitary apoplexy caused by ruptured internal carotid artery aneurysm,” Stroke, vol. 32, no. 2, pp. 567–569, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. C.-C. Chuang, C.-N. Chang, K.-C. Wei et al., “Surgical treatment for severe visual compromised patients after pituitary apoplexy,” Journal of Neuro-Oncology, vol. 80, no. 1, pp. 39–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Verrees, B. M. Arafah, and W. R. Selman, “Pituitary tumor apoplexy: characteristics, treatment, and outcomes,” Neurosurgical Focus, vol. 16, article E6, 2004. View at Google Scholar · View at Scopus
  88. M. J. Ebersold, E. R. Laws Jr., B. W. Scheithauer, and R. V. Randall, “Pituitary apoplexy treated by transsphenoidal surgery. a clinicopathological and immunocytochemical study,” Journal of Neurosurgery, vol. 58, no. 3, pp. 315–320, 1983. View at Publisher · View at Google Scholar · View at Scopus
  89. R. M. McFadzean, D. Doyle, R. Rampling, E. Teasdale, and G. Teasdale, “Pituitary apoplexy and its effect on vision,” Neurosurgery, vol. 29, no. 5, pp. 669–675, 1991. View at Publisher · View at Google Scholar · View at Scopus
  90. P. Maccagnan, C. L. D. Macedo, M. J. Kayath, R. G. Nogueira, and J. Abucham, “Conservative management of pituitary apoplexy: A Prospective Study,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 7, pp. 2190–2197, 1995. View at Google Scholar · View at Scopus
  91. A. B. A. Santos, M. M. França, R. M. Hirosawa, M. Marivo, M. A. Zanini, and V. S. Nunes, “Conservative management of pituitary tumor apoplexy,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 55, no. 5, pp. 345–348, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. M. G. Shaikh, P. Lewis, and J. M. W. Kirk, “Thyroxine unmasks addison's disease,” Acta Paediatrica, International Journal of Paediatrics, vol. 93, no. 12, pp. 1663–1665, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. L. Dawson, C. G. Schaar, P. H. de Meijer, and A. E. Meinders, “Addisonian crisis provoked by levothyroxine substitution therapy,” Ned Tijdschr Geneeskd, vol. 142, pp. 1826–1829, 1998. View at Google Scholar
  94. L. Graves III, R. M. Klein, and A. D. Walling, “Addisonian Crisis precipitated by thyroxine therapy: a complication of type 2 autoimmune polyglandular syndrome,” Southern Medical Journal, vol. 96, no. 8, pp. 824–827, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. J.-W. Seuk, C.-H. Kim, M.-S. Yang, J.-H. Cheong, and J.-M. Kim, “Visual outcome after transsphenoidal surgery in patients with pituitary apoplexy,” Journal of Korean Neurosurgical Society, vol. 49, no. 6, pp. 339–344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Gruber, J. Clayton, S. Kumar, I. Robertson, T. A. Howlett, and P. Mansell, “Pituitary apoplexy: retrospective review of 30 patients—is surgical intervention always necessary?” British Journal of Neurosurgery, vol. 20, no. 6, pp. 379–385, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. D. Agrawal and A. K. Mahapatra, “Visual outcome of blind eyes in pituitary apoplexy after transsphenoidal surgery: a series of 14 eyes,” Surgical Neurology, vol. 63, no. 1, pp. 42–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Peter and N. De Tribolet, “Visual outcome after transsphenoidal surgery for pituitary adenomas,” British Journal of Neurosurgery, vol. 9, no. 2, pp. 151–158, 1995. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Bujawansa, S. K. Thondam, C. Steele et al., “Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom,” Clinical Endocrinology, vol. 80, no. 3, pp. 419–424, 2014. View at Publisher · View at Google Scholar · View at Scopus
  100. D. H. Jho, B. M. K. Biller, P. K. Agarwalla, and B. Swearingen, “Pituitary apoplexy: large surgical series with grading system,” World Neurosurgery, vol. 82, no. 5, pp. 781–790, 2014. View at Publisher · View at Google Scholar · View at Scopus
  101. T. D. Singh, N. Valizadeh, F. B. Meyer, J. L. D. Atkinson, D. Erickson, and A. A. Rabinstein, “Management and outcomes of pituitary apoplexy,” Journal of Neurosurgery, vol. 122, no. 6, pp. 1450–1457, 2015. View at Publisher · View at Google Scholar · View at Scopus
  102. D. I. Rotariu, Z. Faiyad, S. Gaivas, B. F. Iliescu, and I. Poeata, “Pituitary apoplexy management and conditioning factors of outcome,” Acta Endocrinologica, vol. 10, no. 1, pp. 53–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  103. J. Montalbán, J. Sumalla, J. L. Fernandez, A. Molins, R. Simó, and A. Codina, “Empty sella syndrome and pituitary apoplexy,” The Lancet, vol. 331, no. 8588, p. 774, 1988. View at Publisher · View at Google Scholar · View at Scopus
  104. K. Nakahara, H. Oka, S. Utsuki et al., “Pituitary apoplexy manifesting as diffuse subarachnoid hemorrhage,” Neurologia Medico-Chirurgica, vol. 46, no. 12, pp. 594–597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. C. Briet, S. Salenave, J.-F. Bonneville, E. R. Laws, and P. Chanson, “Pituitary apoplexy,” Endocrine Reviews, vol. 36, no. 6, pp. 622–645, 2015. View at Publisher · View at Google Scholar · View at Scopus
  106. B. M. Arafah, J. F. Harrington, Z. T. Madhoun, and W. R. Selman, “Improvement of pituitary function after surgical decompression for pituitary tumor apoplexy,” The Journal of Clinical Endocrinology & Metabolism, vol. 71, no. 2, pp. 323–328, 1990. View at Publisher · View at Google Scholar · View at Scopus
  107. S. Giritharan, K. Gnanalingham, and T. Kearney, “Pituitary apoplexy—bespoke patient management allows good clinical outcome,” Clinical Endocrinology, vol. 85, no. 3, pp. 415–422, 2016. View at Publisher · View at Google Scholar
  108. A. Pal, C. Capatina, A. P. Tenreiro et al., “Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences,” Clinical Endocrinology, vol. 75, no. 4, pp. 501–504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  109. M. Ahmed, A. Rifai, M. Al-Jurf, M. Akhtar, and N. Woodhouse, “Classical pituitary apoplexy presentation and a follow-up of 13 patients,” Hormone Research, vol. 31, no. 3, pp. 125–132, 1989. View at Publisher · View at Google Scholar · View at Scopus
  110. W. L. Bi, I. F. Dunn, and E. R. Laws, “Pituitary apoplexy,” Endocrine, vol. 48, no. 1, pp. 69–75, 2014. View at Publisher · View at Google Scholar · View at Scopus
  111. F. Zhang, J. Chen, Y. Lu, and X. Ding, “Manifestation, management and outcome of subclinical pituitary adenoma apoplexy,” Journal of Clinical Neuroscience, vol. 16, no. 10, pp. 1273–1275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Glezer and M. D. Bronstein, “Pituitary apoplexy: pathophysiology, diagnosis and management,” Archives of Endocrinology and Metabolism, vol. 59, no. 3, pp. 259–264, 2015. View at Publisher · View at Google Scholar